In parallel, the T cell costimulatory molecule inhibitor CTLA4-Ig in pre-RA inhibits progression to RA and decreases image-based inflammation and clinical symptoms (21, 22, 102). This evidence concerns the gene TBXT and rheumatoid arthritis.